tiprankstipranks
Trending News
More News >
Entera Bio Ltd (ENTX)
NASDAQ:ENTX
US Market

Entera Bio (ENTX) Income Statement

Compare
425 Followers

Entera Bio Income Statement

Last quarter (Q3 2025), Entera Bio's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Entera Bio's net income was $-3.20M. See Entera Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 181.00K$ 0.00$ 134.00K$ 571.00K$ 365.00K
Gross Profit
$ 9.00K$ -56.00K$ -31.00K$ 198.00K$ 65.00K
Operating Expenses
$ 9.59M$ 8.88M$ 13.04M$ 12.41M$ 11.23M
Depreciation and Amortization
$ 46.00K$ 56.00K$ 64.00K$ 53.00K$ 63.00K
EBITDA
$ -9.54M$ -8.80M$ -12.87M$ -12.16M$ -11.11M
Operating Income
$ -9.59M$ -8.94M$ -13.07M$ -12.22M$ -11.17M
Other Income/Expenses
$ 58.00K$ 80.00K$ 134.00K$ -29.00K$ -28.00K
Pretax Income
$ -9.53M$ -8.86M$ -12.93M$ -12.25M$ -11.20M
Net Income
$ -9.54M$ -8.89M$ -13.07M$ -12.19M$ -11.22M
Per Share Metrics
Basic EPS
$ -0.25$ -0.31$ -0.45$ -0.47$ -0.54
Diluted EPS
$ -0.25$ -0.31$ -0.45$ -0.47$ -0.54
Weighted Average Shares Outstanding
37.65M 29.01M 28.81M 26.13M 18.42M
Weighted Average Shares Outstanding (Diluted)
37.65M 29.01M 28.81M 26.13M 18.42M
Currency in USD

Entera Bio Earnings and Revenue History